.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Acute bronchitis remains a major clinical challenge, frequently leading to antibiotic overprescription despite its viral origin. In India, the high prevalence of respiratory infections drives antimicrobial resistance when doctors provide inappropriate therapy. Consequently, researchers initiated the EXOTIC trial to evaluate Elixirium thymi compositum as a potential pediatric acute bronchitis treatment. This traditional Hungarian herbal medicine contains thyme extracts that provide symptomatic relief for respiratory conditions.
The EXOTIC trial represents a randomized, double-blind study that seeks to provide clinical evidence for herbal interventions. Specifically, the protocol includes 56 patients aged 6 to 17 years who exhibit a Bronchitis Severity Score between 5 and 12 points. Furthermore, investigators will assign participants to receive either the elixir or a placebo for five days. This study evaluates symptom improvement by Day 7 as its primary endpoint. Additionally, the research team will monitor safety and tolerability to ensure pediatric safety.
Thyme extracts contain active components like thymol and carvacrol which exhibit antimicrobial and expectorant properties. Therefore, these compounds help manage cough and mucus clearance without requiring antibiotics. Moreover, the study directly supports antibiotic stewardship efforts in the Indian context. By validating herbal alternatives, healthcare providers can reduce the pressure for antimicrobial resistance. Ultimately, this research provides a scientific foundation for including herbal products in clinical guidelines for pediatric acute bronchitis treatment.
Since most cases of acute bronchitis are viral, antibiotics are generally ineffective. Evidence-based herbal treatments provide symptomatic relief and help avoid the unnecessary use of antibiotics, which is a major contributor to global drug resistance.
The BSS is a validated clinical tool that allows researchers to objectively measure symptoms such as cough, sputum, and chest pain. This scoring system ensures that data regarding the efficacy of a treatment is consistent and measurable.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The EXOTIC trial is a new randomized controlled study assessing the efficacy of a traditional thyme elixir for treating acute bronchitis in children....
4 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
